| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |